Please provide your email address to receive an email when new articles are posted on . Phase 3 clinical trial included 134 adults with full neuroaxis MRI and no new NMOSD symptoms. At 28 weeks, 15% ...
On Sept. 18, Valentina Cigliola, an assistant professor from Vanderbilt University’s Department of Pharmacology, presented ...
Using advanced methodology, scientists have been able to reveal at the cellular level how lesions in multiple sclerosis develop. Using advanced methodology, scientists in Sweden were able to reveal at ...
MS is a condition in which the immune system attacks the protective covering of the nerves in your brain and spinal cord. These damaged areas are called lesions and are part of an MS diagnosis. Share ...
There are predominantly 2 patterns of NMOSD: monophasic and relapsing. Monophasic NMOSD is diagnosed in approximately 10% of patients and occurs when 1 or both optic nerves and spinal cord are ...
DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of a new analysis of MRI data from the Phase 3 clinical trial of UPLIZNA showing a reduction in the ...
COVID-19 infection is associated with ischemic and hemorrhagic spinal stroke, with distinct clinical characteristics and underlying mechanisms.
BUFFALO, N.Y. – Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an ...
In samples of the spinal cord from four deceased MS patients, 260 genes were simultaneously analyzed and the cellular architecture of the lesions could be determined. The authors also found new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback